Business
Capital Markets Day & Notice of trading update
Capital Markets Day & Notice of trading update.
About this update from Hvivo Plc
[{"type":"text","content":"\n\nhVIVO plc\n(\"hVIVO\", the \"Company\" or the \"Group\")\n \nCapital Markets Event and Trading Update on 17 July\n \nhVIVO plc (AIM & Euronext: HVO), a fast growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces that it will be holding a Capital Markets Event at the Company's new state-of-the-art facility in Canary Wharf for analysts, institutional investors, and media on Wednesday 17 July 2024 at 10.00 am - 12.30 pm (BST). The Company also expects to announce a trading update for the six months ended 30 June 2024 on the same day.\n \nThe event will focus on the capabilities of the world's largest human challenge trial unit and how it will enhance and broaden hVIVO's services, as well as covering the Group's trading update. CEO Yamin 'Mo' Khan will chair the event that will include speakers from across the Group, as well as a fireside chat with a number of external speakers discussing the utility of human challenge trials. There will also be an opportunity for attendees to take part in Q&A sessions with the speakers and to tour the laboratory and challenge trial unit.\n \nAnalysts, institutional investors and media are welcome to attend the in-person event. Due to restrictions on numbers, it will not be possible for all interested parties to attend in-person, however, a live webcast will be available on the Company's website for retail investors and others to view the presentations here.\n \nTo register your interest for the event or webcast, please contact Walbrook PR on +44 20 7933 8780 or email [email protected]. A recording of the presentation will be made available on the Company's website after the event.\n \nFor further information please contact:\n \n\n\n\n\nhVIVO plc\n\n\n+44 (0) 20 7756 1300\n\n\n\n\nYamin 'Mo' Khan, Chief Executive Officer\nStephen Pinkerton, Chief Financial Officer\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCavendish Capital Markets Limited (Nominated Adviser and Joint Broker)\n\n\n+44 (0) 20 7220 0500\n\n\n\n\nGeoff Nash, Charlie Beeson, Nigel Birks, Harriet Ward\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nPeel Hunt LLP (Joint Broker)\n\n\n+44 (0)20 7418 8900\n\n\n\n\nJames Steel, Dr Christopher Golden\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nDavy (Euronext Growth ...